MOLECULAR TEMPLATES INC

MTEMQ

Current Valuation

--P/E
Stock price--

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
021426384

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-60.93x151.28%$197.40B
MRNAUSModerna
-27.13x17.00%$85.50B
CSLLYUSCSL Limited
-25.82x--$66.59B
NTRAUSNatera
-318.06x5.57%$61.18B
RVMDUSRevolution Medicines
-22.88x61.94%$40.45B
ROIVUSRoivant Sciences
-100.68x146.69%$26.81B
BNTXUSBioNTech SE
-11.31x18.75%$22.10B
INSMUSInsmed
-24.20x75.01%$21.18B
BBIOUSBridgebio Pharma
-20.01x27.56%$13.84B
SMMTUSSummit Therapeutics
-14.70x20.08%$12.58B
TWSTUSTwist Bioscience
-83.52x28.63%$11.42B
KYMRUSKymera Therapeutics
-34.00x5.24%$10.19B
MDGLUSMadrigal Pharma
-30.63x51.30%$9.96B
PCVXUSVaxcyte
-9.09x47.91%$9.67B
IBRXUSImmunityBio
-9.41x151.32%$9.34B
SYREUSSpyre Therapeutics
-58.55x45.60%$8.80B
CYTKUSCytokinetics
-9.53x6.85%$8.52B
ARWRUSArrowHead Pharma
-26.58x35,923.70%$8.50B
PRAXUSPraxis Precision Medicines
-23.50x3.71%$7.97B
ABVXUSAbivax SA
-16.84x22.99%$7.83B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.